Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma
about
Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionPrognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.Correlation between the expression of vegf and survival in osteosarcomaEmerging therapeutic targets for synovial sarcoma.Improved survival in osteosarcoma patients with atypical low vascularization.Prognostic value and in vitro biological relevance of Neuropilin 1 and Neuropilin 2 in osteosarcoma.The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanismsExpression of Id-1 and VEGF in non-small cell lung cancer.Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility.A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.Significance of MTA1 in the molecular characterization of osteosarcoma.Does rarity mean imparity? Biological characteristics of osteosarcoma cells originating from the spine.miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma CellsVascular patterning in human heterotopic ossification.Anti-angiogenesis target therapy for advanced osteosarcoma (Review).Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma.Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population.
P2860
Q26829949-D29B03D3-F919-472E-A743-9090ACB2EE87Q33805555-18D64F5E-B215-4A5B-B49D-91B1AB6B7076Q34351720-201F1DCD-7632-49BC-99A2-4F609ACFE9D5Q34660607-6D8C1FC3-6383-4AC8-A08B-A3EF3AFAF000Q35231406-A3655A76-E652-413C-8D8D-D36B019A26C1Q35663028-BB4E73F8-0289-46D1-B6E7-F291E69ED482Q36500327-5097EABB-E43A-4887-BEA9-6FC1A30CE1B1Q37228842-8CAA238D-6A99-4355-A9FF-D2E3984D7B56Q37565250-F16BBA57-6B7B-4BBC-A0E2-2BCADBC8A02EQ38099265-FAB9E820-F3F7-4522-935D-89231ABDC2CFQ38260257-C6BF6AB4-05F3-41D9-A3E2-FC3C582DE1DFQ38702037-593BEAF7-3DAE-4340-950C-FDCF1E09790BQ38737366-BB7F01E6-801A-46A2-8D0A-FB0EF6A2FEF9Q38743308-361A504C-9C1E-4866-8F8D-10E56A4D13D0Q39401628-92A937F2-1A66-446C-AEC5-AB25EA94E46BQ40593958-2DA1B872-53F0-4EB3-AF5C-4FCE060AC6A1Q42317538-8B39C408-C66C-4E42-B80E-838AB03D34FEQ44122884-416E2406-B3F8-4294-886F-083445136EE9
P2860
Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Expression of Vascular Endothe ...... vance of clinical osteosarcoma
@ast
Expression of Vascular Endothe ...... vance of clinical osteosarcoma
@en
type
label
Expression of Vascular Endothe ...... vance of clinical osteosarcoma
@ast
Expression of Vascular Endothe ...... vance of clinical osteosarcoma
@en
prefLabel
Expression of Vascular Endothe ...... vance of clinical osteosarcoma
@ast
Expression of Vascular Endothe ...... vance of clinical osteosarcoma
@en
P2093
P2860
P1476
Expression of Vascular Endothe ...... vance of clinical osteosarcoma
@en
P2093
Elizabeth Rinehart
George Lucas
Gerardo Vergara
Howard G Rosenthal
John Lammli
Meghan Patni
Minyan Fan
Paul H Wooley
P2860
P2888
P304
P356
10.1007/S00264-012-1629-Z
P577
2012-08-02T00:00:00Z